{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:25:36Z","timestamp":1781551536717,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Key Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071600"],"award-info":[{"award-number":["82071600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key R&D Program of China","award":["2023YFC2308200"],"award-info":[{"award-number":["2023YFC2308200"]}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"crossref","award":["JQX21004"],"award-info":[{"award-number":["JQX21004"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13402-025-01063-8","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:29:14Z","timestamp":1744201754000},"page":"1047-1065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Lijie","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingman","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"8","key":"1063_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"M. Singer, C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G.R. Bernard, J.D. Chiche, C.M. Coopersmith, R.S. Hotchkiss, M.M. Levy, J.C. Marshall, G.S. Martin, S.M. Opal, G.D. Rubenfeld, T. van der Poll, J.L. Vincent, D.C. Angus, The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016)","journal-title":"JAMA"},{"issue":"5","key":"1063_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"B.G. Chousterman, F.K. Swirski, G.F. Weber, Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 39(5), 517\u2013528 (2017)","journal-title":"Semin Immunopathol."},{"issue":"11","key":"1063_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/s41591-021-01503-6","volume":"27","author":"J Blazkova","year":"2021","unstructured":"J. Blazkova, F. Gao, M.H. Marichannegowda, J.S. Justement, V. Shi, E.J. Whitehead, R.F. Schneck, E.D. Huiting, K. Gittens, M. Cottrell, E. Benko, C. Kovacs, J. Lack, M.C. Sneller, S. Moir, A.S. Fauci, T.W. Chun, Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy. Nat. Med. 27(11), 1893\u20131898 (2021)","journal-title":"Nat. Med."},{"issue":"6","key":"1063_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41590-020-0673-x","volume":"21","author":"A Roquilly","year":"2020","unstructured":"A. Roquilly, C. Jacqueline, M. Davieau, A. Molle, A. Sadek, C. Fourgeux, P. Rooze, A. Broquet, B. Misme-Aucouturier, T. Chaumette, M. Vourc\u2019h, R. Cinotti, N. Marec, V. Gauttier, H.E.G. McWilliam, F. Altare, J. Poschmann, J.A. Villadangos, K. Asehnoune, Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat. Immunol. 21(6), 636\u2013648 (2020)","journal-title":"Nat. Immunol."},{"issue":"3","key":"1063_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/1744666X.2019.1562336","volume":"15","author":"N Bruse","year":"2019","unstructured":"N. Bruse, G.P. Leijte, P. Pickkers, M. Kox, New frontiers in precision medicine for sepsis-induced immunoparalysis. Expert Rev. Clin. Immunol. 15(3), 251\u2013263 (2019)","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"10","key":"1063_CR6","doi-asserted-by":"publisher","first-page":"e1007405","DOI":"10.1371\/journal.ppat.1007405","volume":"14","author":"IJ Jensen","year":"2018","unstructured":"I.J. Jensen, C.S. Winborn, M.G. Fosdick, P. Shao, M.M. Tremblay, Q. Shan, S.K. Tripathy, C.M. Snyder, H.H. Xue, T.S. Griffith, J.C. Houtman, V.P. Badovinac, Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 14(10), e1007405 (2018)","journal-title":"PLoS Pathog"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3389\/fimmu.2018.02532","volume":"9","author":"FV Sjaastad","year":"2018","unstructured":"F.V. Sjaastad, S.A. Condotta, J.A. Kotov, K.A. Pape, C. Dail, D.B. Danahy, T.A. Kucaba, L.T. Tygrett, K.A. Murphy, J. Cabrera-Perez, T.J. Waldschmidt, V.P. Badovinac, T.S. Griffith, Polymicrobial sepsis chronic immunoparalysis is defined by diminished Ag-Specific T cell-Dependent B cell responses. Front. Immunol. 9, 2532 (2018)","journal-title":"Front. Immunol."},{"issue":"12","key":"1063_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"R.S. Hotchkiss, G. Monneret, D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13(12), 862\u2013874 (2013)","journal-title":"Nat. Rev. Immunol."},{"key":"1063_CR9","unstructured":"X. Liu, L. Yin, S. Shen, Y. Hou, Inflammation and Cancer: Paradoxical Roles in Tumorigenesis and Implications in Immunotherapies (Genes & Diseases, 2021)"},{"issue":"5","key":"1063_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/cid\/ciy530","volume":"68","author":"Z Liu","year":"2019","unstructured":"Z. Liu, P. Mahale, E.A. Engels, Sepsis and risk of cancer among elderly adults in the united States. Clin. Infect. Dis. 68(5), 717\u2013724 (2019)","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"1063_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2326-6066.CIR-15-0170","volume":"4","author":"JM Mota","year":"2016","unstructured":"J.M. Mota, C.A. Leite, L.E. Souza, P.H. Melo, D.C. Nascimento, V.M. de-Deus-Wagatsuma, J. Temporal, F. Figueiredo, H. Noushmehr, J.C. Alves-Filho, F.Q. Cunha, E.M. Rego, Post-Sepsis state induces tumor-Associated macrophage accumulation through CXCR4\/CXCL12 and favors tumor progression in mice. Cancer Immunol. Res. 4(4), 312\u2013322 (2016)","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"1063_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","volume":"177","author":"S Yende","year":"2008","unstructured":"S. Yende, G. D\u2019Angelo, J.A. Kellum, L. Weissfeld, J. Fine, R.D. Welch, L. Kong, M. Carter, D.C. Angus, I.M.S.I. Gen, Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am. J. Respir Crit. Care Med. 177(11), 1242\u20131247 (2008)","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"4","key":"1063_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"M. Philip, A. Schietinger, CD8(+) T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22(4), 209\u2013223 (2022)","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"1063_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4049\/jimmunol.1900435","volume":"203","author":"DB Danahy","year":"2019","unstructured":"D.B. Danahy, S.P. Kurup, C.S. Winborn, I.J. Jensen, J.T. Harty, T.S. Griffith, V.P. Badovinac, Sepsis-Induced state of immunoparalysis is defined by diminished CD8 T Cell-Mediated antitumor immunity. J. Immunol. 203(3), 725\u2013735 (2019)","journal-title":"J. Immunol."},{"key":"1063_CR15","doi-asserted-by":"crossref","unstructured":"L. Cassetta, K. Bruderek, J. Skrzeczynska-Moncznik, O. Osiecka, X. Hu, I.M. Rundgren, A. Lin, K. Santegoets, U. Horzum, A. Godinho-Santos, G. Zelinskyy, T. Garcia-Tellez, S. Bjelica, B. Taciak, A.O. Kittang, B. Hoing, S. Lang, M. Dixon, V. Muller, J.S. Utikal, D. Karakoc, K.B. Yilmaz, E. Gorka, L. Bodnar, O.E. Anastasiou, C. Bourgeois, R. Badura, M. Kapinska-Mrowiecka, M. Gotic, M. Ter Laan, E. Kers-Rebel, M. Krol, J.F. Santibanez, M. Muller-Trutwin, U. Dittmer, A.E. de Sousa, G. Esendagli, G. Adema, K. Lore, E. Ersvaer, V. Umansky, J.W. Pollard, J. Cichy, S. Brandau, Differential expansion of Circulating human MDSC subsets in patients with cancer, infection and inflammation. J. Immunother Cancer. 8(2), (2020).","DOI":"10.1136\/jitc-2020-001223"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","volume":"532","author":"X Zhou","year":"2022","unstructured":"X. Zhou, D. Fang, H. Liu, X. Ou, C. Zhang, Z. Zhao, S. Zhao, J. Peng, S. Cai, Y. He, J. Xu, PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer. Cancer Lett. 532, 215598 (2022)","journal-title":"Cancer Lett."},{"issue":"2","key":"1063_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"F. Venet, G. Monneret, Advances in the Understanding and treatment of sepsis-induced immunosuppression. Nat. Rev. Nephrol. 14(2), 121\u2013137 (2018)","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"1063_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","volume":"26","author":"K Taniguchi","year":"2014","unstructured":"K. Taniguchi, M. Karin, IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 26(1), 54\u201374 (2014)","journal-title":"Semin Immunol."},{"issue":"1","key":"1063_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13287-021-02206-y","volume":"12","author":"Y Li","year":"2021","unstructured":"Y. Li, Y. Xu, X. Liu, X. Yan, Y. Lin, Q. Tan, Y. Hou, mTOR inhibitor INK128 promotes wound healing by regulating MDSCs. Stem Cell. Res. Ther. 12(1), 170 (2021)","journal-title":"Stem Cell. Res. Ther."},{"issue":"7","key":"1063_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","volume":"18","author":"WJM Mulder","year":"2019","unstructured":"W.J.M. Mulder, J. Ochando, L.A.B. Joosten, Z.A. Fayad, M.G. Netea, Therapeutic targeting of trained immunity. Nat. Rev. Drug Discov. 18(7), 553\u2013566 (2019)","journal-title":"Nat. Rev. Drug Discov"},{"issue":"2","key":"1063_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.7150\/thno.64874","volume":"12","author":"Y Pan","year":"2022","unstructured":"Y. Pan, J. Li, X. Xia, J. Wang, Q. Jiang, J. Yang, H. Dou, H. Liang, K. Li, Hou, beta-glucan-coupled superparamagnetic iron oxide nanoparticles induce trained immunity to protect mice against sepsis. Theranostics. 12(2), 675\u2013688 (2022)","journal-title":"Theranostics"},{"issue":"2","key":"1063_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.7150\/ijbs.53050","volume":"17","author":"Z Sun","year":"2021","unstructured":"Z. Sun, J. Qu, X. Xia, Y. Pan, X. Liu, H. Liang, H. Dou, Y. Hou, 17beta-Estradiol promotes LC3B-associated phagocytosis in trained immunity of female mice against sepsis. Int. J. Biol. Sci. 17(2), 460\u2013474 (2021)","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"1063_CR23","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/ptr.5694","volume":"30","author":"L Lu","year":"2016","unstructured":"L. Lu, Q. Guo, L. Zhao, Overview of oroxylin A: A promising flavonoid compound. Phytother Res. 30(11), 1765\u20131774 (2016)","journal-title":"Phytother Res."},{"key":"1063_CR24","doi-asserted-by":"crossref","unstructured":"L. Yin, Z. Bing, Y. Zheng, Y. Pan, Y. Dong, J. Wang, R. Luo, Y. Zhao, H. Dou, Y. Hou, Oroxylin A-induced Trained Immunity Promotes LC3-associated Phagocytosis in Macrophage in Protecting Mice against Sepsis (Inflammation, 2024)","DOI":"10.1007\/s10753-024-02033-2"},{"issue":"10","key":"1063_CR25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/carcin\/bgy004","volume":"39","author":"H Li","year":"2018","unstructured":"H. Li, N. Lu, X. Yu, X. Liu, P. Hu, Y. Zhu, L. Shen, J. Xu, Z. Li, Q. Guo, H. Hui, Oroxylin A, a natural compound, mitigates the negative effects of TNFalpha-treated acute myelogenous leukemia cells. Carcinogenesis. 39(10), 1292\u20131303 (2018)","journal-title":"Carcinogenesis"},{"issue":"6","key":"1063_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/CMR.0000000000000853","volume":"32","author":"L Yin","year":"2022","unstructured":"L. Yin, X. Liu, J. Wu, J. Yang, J. Wang, H. Dou, Y. Hou, LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization. Melanoma Res. 32(6), 419\u2013427 (2022)","journal-title":"Melanoma Res."},{"issue":"7","key":"1063_CR27","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/all.15692","volume":"78","author":"H Movassagh","year":"2023","unstructured":"H. Movassagh, M. Prunicki, A. Kaushik, X. Zhou, D. Dunham, E.M. Smith, Z. He, G.R. Aleman Muench, M. Shi, A.K. Weimer, S. Cao, S. Andorf, A. Feizi, M.P. Snyder, P. Soroosh, E.D. Mellins, K.C. Nadeau, Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma. Allergy. 78(7), 1922\u20131933 (2023)","journal-title":"Allergy"},{"key":"1063_CR28","doi-asserted-by":"crossref","unstructured":"E. Jentho, C. Ruiz-Moreno, B. Novakovic, I. Kourtzelis, W.L. Megchelenbrink, R. Martins, T. Chavakis, M.P. Soares, L. Kalafati, J. Guerra, F. Roestel, P. Bohm, M. Godmann, T. Grinenko, A. Eugster, M. Beretta, L.A.B. Joosten, M.G. Netea, M. Bauer, H.G. Stunnenberg, S. Weis, Trained Innate Immunity, long-lasting Epigenetic Modulation, and Skewed Myelopoiesis by Heme (Proc Natl Acad Sci U S A, 2021). 118(42)","DOI":"10.1073\/pnas.2102698118"},{"issue":"1","key":"1063_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.it.2018.11.006","volume":"40","author":"RM Rodriguez","year":"2019","unstructured":"R.M. Rodriguez, B. Suarez-Alvarez, C. Lopez-Larrea, Therapeutic epigenetic reprogramming of trained immunity in myeloid cells. Trends Immunol. 40(1), 66\u201380 (2019)","journal-title":"Trends Immunol."},{"issue":"6204","key":"1063_CR30","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"S.C. Cheng, J. Quintin, R.A. Cramer, K.M. Shepardson, S. Saeed, V. Kumar, E.J. Giamarellos-Bourboulis, J.H. Martens, N.A. Rao, A. Aghajanirefah, G.R. Manjeri, Y. Li, D.C. Ifrim, R.J. Arts, B.M. van der Veer, P.M. Deen, C. Logie, L.A. O\u2019Neill, P. Willems, F.L. van de Veerdonk, J.W. van der Meer, A. Ng, L.A. Joosten, C. Wijmenga, H.G. Stunnenberg, R.J. Xavier, M.G. Netea, mTOR- and HIF-1alpha-mediated aerobic Glycolysis as metabolic basis for trained immunity. Science. 345(6204), 1250684 (2014)","journal-title":"Science"},{"key":"1063_CR31","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"V. Bronte, S. Brandau, S.H. Chen, M.P. Colombo, A.B. Frey, T.F. Greten, S. Mandruzzato, P.J. Murray, A. Ochoa, S. Ostrand-Rosenberg, P.C. Rodriguez, A. Sica, V. Umansky, R.H. Vonderheide, D.I. Gabrilovich, Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150 (2016)","journal-title":"Nat. Commun."},{"issue":"1","key":"1063_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-024-47096-9","volume":"15","author":"S Daneshmandi","year":"2024","unstructured":"S. Daneshmandi, J.E. Choi, Q. Yan, C.R. MacDonald, M. Pandey, M. Goruganthu, N. Roberts, P.K. Singh, R.M. Higashi, A.N. Lane, T.W. Fan, J. Wang, P.L. McCarthy, E.A. Repasky, H. Mohammadpour, Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies. Nat. Commun. 15(1), 2803 (2024)","journal-title":"Nat. Commun."},{"issue":"8","key":"1063_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, V.A. Lennon, E. Celis, L. Chen, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8(8), 793\u2013800 (2002)","journal-title":"Nat. Med."},{"key":"1063_CR34","doi-asserted-by":"crossref","unstructured":"W.S. Ruan, M.X. Feng, J. Xu, Y.G. Xu, C.Y. Song, L.Y. Lin, L. Li, Y.Q. Lu, Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression Via PD-L1\/PD-1 Axis, vol. 11 (Front Immunol, 2020), p. 1299","DOI":"10.3389\/fimmu.2020.01299"},{"issue":"2","key":"1063_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41590-022-01388-8","volume":"24","author":"C Ding","year":"2023","unstructured":"C. Ding, R. Shrestha, X. Zhu, A.E. Geller, S. Wu, M.R. Woeste, W. Li, H. Wang, F. Yuan, R. Xu, J.H. Chariker, X. Hu, H. Li, D. Tieri, H.G. Zhang, E.C. Rouchka, R. Mitchell, L.J. Siskind, X. Zhang, X.G. Xu, K.M. McMasters, Y. Yu, Yan, inducing trained immunity in pro-metastatic macrophages to control tumor metastasis. Nat. Immunol. 24(2), 239\u2013254 (2023)","journal-title":"Nat. Immunol."},{"issue":"1","key":"1063_CR36","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1038\/s41598-021-87613-0","volume":"11","author":"J Toldi","year":"2021","unstructured":"J. Toldi, D. Nemeth, P. Hegyi, Z. Molnar, M. Solymar, N. Farkas, H. Alizadeh, Z. Rumbus, E. Pakai, A. Garami, Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials. Sci. Rep. 11(1), 8051 (2021)","journal-title":"Sci. Rep."},{"issue":"7","key":"1063_CR37","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.drudis.2021.03.012","volume":"26","author":"A Osipyan","year":"2021","unstructured":"A. Osipyan, D. Chen, F.J. Dekker, Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation. Drug Discov Today. 26(7), 1728\u20131734 (2021)","journal-title":"Drug Discov Today"},{"issue":"1","key":"1063_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"M.J. Delano, P.A. Ward, Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 126(1), 23\u201331 (2016)","journal-title":"J. Clin. Invest."},{"key":"1063_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13054-016-1233-5","volume":"20","author":"C Arens","year":"2016","unstructured":"C. Arens, S.A. Bajwa, C. Koch, B.H. Siegler, E. Schneck, A. Hecker, S. Weiterer, C. Lichtenstern, M.A. Weigand, F. Uhle, Sepsis-induced long-term immune paralysis\u2013results of a descriptive, explorative study. Crit. Care. 20, 93 (2016)","journal-title":"Crit. Care"},{"issue":"24","key":"1063_CR40","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","volume":"118","author":"EK Lindqvist","year":"2011","unstructured":"E.K. Lindqvist, L.R. Goldin, O. Landgren, C. Blimark, U.H. Mellqvist, I. Turesson, A. Wahlin, M. Bjorkholm, S.Y. Kristinsson, Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood. 118(24), 6284\u20136291 (2011)","journal-title":"Blood"},{"issue":"1","key":"1063_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canep.2013.10.009","volume":"38","author":"GJ Titmarsh","year":"2014","unstructured":"G.J. Titmarsh, M.F. McMullin, C.M. McShane, M. Clarke, E.A. Engels, L.A. Anderson, Community-acquired infections and their association with myeloid malignancies. Cancer Epidemiol. 38(1), 56\u201361 (2014)","journal-title":"Cancer Epidemiol."},{"key":"1063_CR42","doi-asserted-by":"crossref","unstructured":"B. Zhang, S.J. Moorlag, J. Dominguez-Andres, O. Bulut, G. Kilic, Z. Liu, R. van Crevel, C.J. Xu, L.A. Joosten, M.G. Netea, Y. Li, Single-cell RNA sequencing reveals induction of distinct trained-immunity programs in human monocytes. J. Clin. Invest., (2022). 132(7).","DOI":"10.1172\/JCI147719"},{"issue":"11","key":"1063_CR43","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41590-021-01052-7","volume":"22","author":"N Katzmarski","year":"2021","unstructured":"N. Katzmarski, J. Dominguez-Andres, B. Cirovic, G. Renieris, E. Ciarlo, D. Le Roy, K. Lepikhov, K. Kattler, G. Gasparoni, K. Handler, H. Theis, M. Beyer, J.W.M. van der Meer, L.A.B. Joosten, J. Walter, J.L. Schultze, T. Roger, E.J. Giamarellos-Bourboulis, A. Schlitzer, M.G. Netea, Transmission of trained immunity and heterologous resistance to infections across generations. Nat. Immunol. 22(11), 1382\u20131390 (2021)","journal-title":"Nat. Immunol."},{"key":"1063_CR44","doi-asserted-by":"crossref","unstructured":"B. Novakovic, E. Habibi, S.Y. Wang, R.J.W. Arts, R. Davar, W. Megchelenbrink, B. Kim, T. Kuznetsova, M. Kox, J. Zwaag, F. Matarese, S.J. van Heeringen, E.M. Janssen-Megens, N. Sharifi, C. Wang, F. Keramati, V. Schoonenberg, P. Flicek, L. Clarke, P. Pickkers, S. Heath, I. Gut, M.G. Netea, J.H.A. Martens, C. Logie, and H.G. Stunnenberg, beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance. Cell, (2016). 167(5): pp. 1354\u20131368 e14","DOI":"10.1016\/j.cell.2016.09.034"},{"issue":"29","key":"1063_CR45","doi-asserted-by":"publisher","first-page":"e2400413121","DOI":"10.1073\/pnas.2400413121","volume":"121","author":"HR Knight","year":"2024","unstructured":"H.R. Knight, E. Ketter, T. Ung, A. Weiss, J. Ajit, Q. Chen, J. Shen, K.M. Ip, C.Y. Chiang, L. Barreiro, A. Esser-Kahn, High-throughput screen identifies Non inflammatory small molecule inducers of trained immunity. Proc. Natl. Acad. Sci. U S A 121(29), e2400413121 (2024)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"1063_CR46","doi-asserted-by":"publisher","first-page":"e198686","DOI":"10.1001\/jamanetworkopen.2019.8686","volume":"2","author":"S Yende","year":"2019","unstructured":"S. Yende, J.A. Kellum, V.B. Talisa, O.M. Peck Palmer, C.H. Chang, M.R. Filbin, N.I. Shapiro, P.C. Hou, A. Venkat, F. LoVecchio, K. Hawkins, E.D. Crouser, A.B. Newman, D.C. Angus, Long-term host immune response trajectories among hospitalized patients with sepsis. JAMA Netw. Open. 2(8), e198686 (2019)","journal-title":"JAMA Netw. Open."},{"issue":"7","key":"1063_CR47","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.jid.2021.12.012","volume":"142","author":"Y Wang","year":"2022","unstructured":"Y. Wang, V. Ramachandran, D. Sui, K. Xu, L.E. Haydu, S. Fang, J.L. McQuade, S.B. Fisher, A. Lucci, E.Z. Keung, J. Wargo, J.E. Gershenwald, M.I. Ross, J.E. Lee, Evaluation of plasma IL-6 in patients with melanoma as a prognostic and checkpoint immunotherapy predictive biomarker. J. Invest. Dermatol. 142(7), 2046\u20132049 (2022). e3","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"1063_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.molonc.2014.05.008","volume":"8","author":"R Linnskog","year":"2014","unstructured":"R. Linnskog, G. Jonsson, L. Axelsson, C.P. Prasad, T. Andersson, Interleukin-6 drives melanoma cell motility through p38alpha-MAPK-dependent up-regulation of WNT5A expression. Mol. Oncol. 8(8), 1365\u20131378 (2014)","journal-title":"Mol. Oncol."},{"key":"1063_CR49","doi-asserted-by":"crossref","unstructured":"R. Weber, Z. Riester, L. Huser, C. Sticht, A. Siebenmorgen, C. Groth, X. Hu, P. Altevogt, J.S. Utikal, V. Umansky, IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. J. Immunother Cancer, (2020). 8(2)","DOI":"10.1136\/jitc-2020-000949"},{"key":"1063_CR50","doi-asserted-by":"crossref","unstructured":"M. Thiele, S.C. Donnelly, R.A. Mitchell, OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases. J. Immunother Cancer, (2022). 10(9)","DOI":"10.1136\/jitc-2022-005475"},{"issue":"6","key":"1063_CR51","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","volume":"190","author":"K Yaddanapudi","year":"2013","unstructured":"K. Yaddanapudi, K. Putty, B.E. Rendon, G.J. Lamont, J.D. Faughn, A. Satoskar, A. Lasnik, J.W. Eaton, R.A. Mitchell, Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. J. Immunol. 190(6), 2984\u20132993 (2013)","journal-title":"J. Immunol."},{"issue":"1","key":"1063_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-018-0614-4","volume":"11","author":"RE Piddock","year":"2018","unstructured":"R.E. Piddock, C.R. Marlein, A. Abdul-Aziz, M.S. Shafat, M.J. Auger, K.M. Bowles, S.A. Rushworth, Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC. J. Hematol. Oncol. 11(1), 66 (2018)","journal-title":"J. Hematol. Oncol."},{"key":"1063_CR53","doi-asserted-by":"publisher","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","volume":"359","author":"R Weber","year":"2021","unstructured":"R. Weber, C. Groth, S. Lasser, I. Arkhypov, V. Petrova, P. Altevogt, J. Utikal, V. Umansky, IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell. Immunol. 359, 104254 (2021)","journal-title":"Cell. Immunol."},{"issue":"6","key":"1063_CR54","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"B.E. Lippitz, Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 14(6), e218\u2013e228 (2013)","journal-title":"Lancet Oncol."},{"issue":"2","key":"1063_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-021-03426-z","volume":"12","author":"L Klemke","year":"2021","unstructured":"L. Klemke, T. De Oliveira, D. Witt, N. Winkler, H. Bohnenberger, R. Bucala, L.C. Conradi, R. Schulz-Heddergott, Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell. Death Dis. 12(2), 155 (2021)","journal-title":"Cell. Death Dis."},{"issue":"1","key":"1063_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12944-022-01693-z","volume":"21","author":"M Yang","year":"2022","unstructured":"M. Yang, S. Wu, W. Cai, X. Ming, Y. Zhou, X. Chen, Hypoxia-induced MIF induces dysregulation of lipid metabolism in Hep2 laryngocarcinoma through the IL-6\/JAK-STAT pathway. Lipids Health Dis. 21(1), 82 (2022)","journal-title":"Lipids Health Dis."},{"issue":"10","key":"1063_CR57","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.4049\/jimmunol.1900076","volume":"202","author":"DB Danahy","year":"2019","unstructured":"D.B. Danahy, I.J. Jensen, T.S. Griffith, V.P. Badovinac, Cutting edge: polymicrobial sepsis has the capacity to reinvigorate Tumor-Infiltrating CD8 T cells and prolong host survival. J. Immunol. 202(10), 2843\u20132848 (2019)","journal-title":"J. Immunol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:21:22Z","timestamp":1752139282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01063-8","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the Animal Protection and Ethics Committee of Nanjing University (IACUC-D2202077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"All experiments involving animals were conducted according to the ethical policies and procedures approved by the Animal Protection and Ethics Committee of Nanjing University (IACUC-D2202077).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics requirements"}},{"value":"The manuscript has been approved by all authors for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}